Literature DB >> 3432171

New treatments in myeloma--is cure possible?

J S Malpas.   

Abstract

Entities:  

Mesh:

Year:  1987        PMID: 3432171      PMCID: PMC2428312          DOI: 10.1136/pgmj.63.740.425

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  9 in total

1.  Comparison of effect of cyclophosphamide and a placebo in treatment of multiple myeloma.

Authors:  S L RIVERS; R M WHITTINGTON; M E PATNO
Journal:  Cancer Chemother Rep       Date:  1963-05

2.  [Clinical experiences with sarcolysin in neoplastic diseases].

Authors:  N BLOKHIN; L LARIONOV; N PEREVODCHIKOVA; L CHEBOTAREVA; N MERKULOVA
Journal:  Ann N Y Acad Sci       Date:  1958-04-24       Impact factor: 5.691

3.  Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU.

Authors:  B J Lee; G Sahakian; B D Clarkson; I H Krakoff
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

Review 4.  Chemotherapy of previously untreated multiple myeloma patients: an analysis of recent treatment results.

Authors:  J R Sporn; O R McIntyre
Journal:  Semin Oncol       Date:  1986-09       Impact factor: 4.929

5.  Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: a Southwest Oncology Group Study.

Authors:  S E Salmon; A Haut; J D Bonnet; M Amare; J K Weick; B G Durie; D O Dixon
Journal:  J Clin Oncol       Date:  1983-08       Impact factor: 44.544

6.  Effective treatment of advanced multiple myeloma refractory to alkylating agents.

Authors:  B Barlogie; L Smith; R Alexanian
Journal:  N Engl J Med       Date:  1984-05-24       Impact factor: 91.245

Review 7.  Treatment of multiple myeloma.

Authors:  R Woodruff
Journal:  Cancer Treat Rev       Date:  1981-12       Impact factor: 12.111

8.  High-dose intravenous melphalan for plasma-cell leukaemia and myeloma.

Authors:  T J McElwain; R L Powles
Journal:  Lancet       Date:  1983-10-08       Impact factor: 79.321

9.  A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Authors:  B G Durie; S E Salmon
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

  9 in total
  1 in total

1.  Problems of myeloma in a community.

Authors:  N G Flanagan; J C Ridway; A Jain; C C Platt; A G Irving
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.